Capstone believes the US fertility market is well-positioned amid increased state and federal action on in vitro fertilization (IVF) policy and access. Recent guidance from the Trump administration may empower employers to expand access to fertility benefits; however,...

Capstone believes investors should focus on four key regulatory dynamics that separate signal from noise in the RCM landscape. Amid regulatory flux that includes Medicaid work requirements, ACA subsidy expiration, and AI restrictions, RCM vendors face a dramatic...